IQInvest research note
25 SEP 2026 · 23:58 ET
CVS
CVS Health Corporation
$89.13
$4.08 (+4.80%)up 4.80%
25 September 2026 · delayed 15+ min
D
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
CVS Health Corporation earns a D on strong earnings growth (>20%) and positive free cash flow but current ratio below 1.0 (liquidity concerns) and high debt-to-equity ratio (>2.0). Reasonable investment with moderate upside potential.
Adjusted for Moderate investors, Medium-term investors 5.1% suggested allocation Change these
IQ-CVS-20260925engine v1 · 7-category weighted scorecard